Litcius/Paper detail

l-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope?

Jennifer Leibovitch, Ajay Tambe, Emanuela Cimpeanu, Maria Poplawska, Firas Jafri, Dibyendu Dutta, Seah H. Lim

2022Blood Reviews34 citationsDOI

Topics & Concepts

MedicineDiseaseContext (archaeology)Clinical trialIntensive care medicineHematopoietic stem cell transplantationCell therapyInternal medicineStem cellOncologyBiologyGeneticsPaleontologyHemoglobinopathies and Related DisordersPrenatal Screening and DiagnosticsParvovirus B19 Infection Studies
l-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope? | Litcius